Categories October Surprise 2016 Prescription Treatment for IBS-D | XIFAXAN® (rifaximin) Post author By Mike Nova Post date June 13, 2026 XIFAXAN ® (rifaximin) 550 mg tablets are indicated for the reduction in risk of overt hepatic encephalopathy (HE) recurrence in adults and for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in adults. ← XIFAXAN® (rifaximin) For Adults with Overt HE and IBS-D → Download and install Google Chrome